SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
REPLIGEN
(NQNM:RGEN Last Sale: 113.94 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (RGEN : $113.94)
$5,934,401 million Market Cap at Market Close, July 1, 2022
Employs 37.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

41 Seyon Street Building 1 Research Report Earnings Snapshot - Last 11/06/18
Waltham, MA 02453 Fact Sheet
Phone: (781) 250-0111 Financial Statements
Peer Comparison
Annual Reports

A. Rich, Co-Chmn., P. Schimmel, Co-Chmn., Walter C. Herlihy, Pres./CEO
Develops and manufactures biopharmaceutical products for cancer, cardiovascular conditions & immunology. Founded in 1981.
Historical Charts    Technical Analysis
No Historical Data available for RGEN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common RGEN $113.94 $113.94 0 .0 $110.44 $114 393,431 $110.44 $114 52,083,563
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

A210
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex